Michael P.Earley

Practice Leader Private Equity

(T) 1.312.269.4349

Connect:

Share

Michael Earley, who co-chairs Jones Day's global Private Equity Practice, is a corporate lawyer with a broad transactional and advisory practice focused on private equity and venture capital transactions. He represents a variety of private equity and real estate funds regarding their formation and governance, including counseling the firms on their internal economic arrangements and compensation matters. He also has experience representing institutional investors, including university endowments and global sovereign investors, in connection with not only their investments in private equity funds, but also their direct investment opportunities. A significant portion of his practice involves international funds and cross-border transactions.

Michael also advises issuers and investors in the formation and financing of private and emerging growth companies in sectors such as transportation and distribution, life sciences, and information services. His work with these private companies includes not only financing transactions, but also counseling them on mergers and acquisitions, strategic relationships, corporate governance, and other general corporate matters.

Some of the clients Michael has recently worked with include AquaBounty Technologies, Baird Capital, Baxalta Ventures, Baxter Ventures, Contrarian Capital, Counsel Capital, Meyer Bergman, Resolution Real Estate, The Riverside Company, TriGate Capital, and Whitman Peterson Partners.

In addition to his legal practice, Michael serves on the board of the Daniel Murphy Scholarship Fund, the auxiliary board of the Chicago Children's Museum, and the Evans Scholars Foundation Leadership Council.

Experience

  • Baird Capital acquires minority stake in AEGIS Energy RiskJones Day represented Baird Capital in connection with its minority stake investment in AEGIS Energy Risk, the leading fintech and advisory solutions provider for energy derivatives.
  • Baird Capital participates in Series A financing round by ChurnZeroJones Day represented Baird Capital in connection with its purchase of Series A Preferred Stock in a private placement by ChurnZero, a real-time customer success platform.
  • Baxter Ventures invests in Prescient SurgicalJones Day represented Baxter Ventures in connection with its purchase of Series B Convertible Preferred Stock in a private placement by Prescient Surgical, Inc., a manufacturer of advanced tools and technologies to fight and defend against the sources of surgical site infection.
  • Baird Capital sells interest in Radius to VistraJones Day represented Baird Capital in connection with its sale of interest in Radius, a leading global accounting and administration company which provides clients with increased resources, an enhanced knowledge base, and a dedicated proprietary software platform, to support overseas office activities, to Vistra.
  • Koch Disruptive Technologies leads $150 million investment in INSIGHTECJones Day advised Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies, as the lead investor in a $150 million Series E funding round for INSIGHTEC, a commercial stage medical device company.
  • Greystar forms open ended core plus fund and acquires Monogram for approximately $4.4 billionJones Day advised Greystar Real Estate Partners on a number of related transactions culminating in the acquisition of Monogram Residential Trust, Inc. (a publicly traded REIT based in Plano, Texas), an owner, operator, and developer of luxury apartment communities with a significant presence in select coastal markets, in a transaction valued at approximately $4.4 billion, including the debt assumed or refinanced in connection with the transaction.
  • Shore Capital Partners portfolio company acquires TheraBond® family of products from Alliqua BioMedicalJones Day represented Shore Capital Partners, LLC in connection with the acquisition by portfolio company, Argentum Medical, LLC, a manufacturer of innovative wound care products, of TheraBond® family of products from Alliqua BioMedical, Inc., a regenerative technologies company committed to restoring tissue and rebuilding lives.
  • Baird Capital invests in Housecall ProJones Day represented Baird Capital in connection with its investment in Housecall Pro, a mobile software solution for home service professionals.
  • Baird Capital invests in AppCastJones Day represented Baird Capital in connection with its purchase of Series B Convertible Preferred Stock in a private placement by AppCast, Inc., a developer of programmatic job advertising technology.
  • AquaBounty completes purchase of Bell Fish Company's aquatic biomass farming facilityJones Day represented AquaBounty Technologies, Inc., a biotechnology company focused on enhancing productivity in the aquaculture market, in connection with its $14 million purchase of Bell Fish Company's aquatic biomass farming facility in Albany, Indiana.
  • Baxter Ventures invests in VitalConnectJones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by VitalConnect, a leader in medical-grade wearable biosensor systems.
  • Shore Capital Partners portfolio company acquires vertebroplasty family of products from Cook MedicalJones Day represented Shore Capital Partners in connection with the acquisition by portfolio company IZI Medical Products, LLC, a manufacturer of medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures, of the vertebroplasty family of products from Cook Medical, a family-owned medical device company.
  • Digital Bridge in consortium with PSP Investments and TIAA Investments acquires Vantage Data CentersJones Day advised a consortium which includes Digital Bridge Holdings, LLC, a leading global communications infrastructure company, Public Sector Pension Investment Board (PSP Investments), and TIAA Investments (an affiliate of Nuveen), on the acquisition and related financing of Vantage Data Centers, a leading provider of data center solutions in support of mission-critical applications.
  • Shore Capital Partners invests in Argentum Medical and acquires certain assets of Cura SurgicalJones Day represented Shore Capital Partners, LLC in connection with its growth investment in Argentum Medical, LLC, a manufacturer and distributor of innovative wound care and surgical care products for consumers and professional, and acquisition of certain assets of Cura Surgical, Inc., a manufacturer and distributor of silver plated nylon technologies, minimally invasive surgical instruments, and implantable devices to surgeons and healthcare facilities.
  • TriGate Capital forms TriGate Property Partners Fund IIIJones Day advised TriGate Capital, LLC in connection with the formation of TriGate Property Partners Fund III, a $340 million real estate opportunity fund.
  • DTE acquires M3's Appalachia Midstream assets for $1.3 billionJones Day advised DTE Energy in its $1.3 billion acquisition of 100 percent of Appalachia Gathering System and 55 percent of Stonewall Gas Gathering, both midstream natural gas assets located in the Appalachia region, from M3 Midstream LLC and Vega Energy Partners.
  • Contrarian Capital Management forms Contrarian Distressed Real Estate Debt Fund III, L.P.Jones Day advised Contrarian Capital Management, LLC in connection with the formation of Contrarian Distressed Real Estate Debt Fund III, L.P., a $382 million real estate debt fund structured with parallel Delaware limited partnerships.
  • Baxter Ventures invests in Kit CheckJones Day represented Baxter International Inc. in connection with its purchase of Series C Convertible Preferred Stock in a private placement by Kit Check, Inc., an automated hospital pharmacy kit processing and medication tracking software.
  • Baxalta invests in OncoResponseJones Day represented Baxalta Inc., a biopharmaceutical manufacturer headquartered in Northern Illinois, in connection with its purchase of Series A Convertible Preferred Stock in a private placement by OncoResponse, an immuno-oncology antibody discovery company.
  • Shore Capital Partners invests in IZI Medical ProductsJones Day represented Shore Capital Partners, LLC in connection with its investment in IZI Medical Products, a manufacturer of medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
    • View All

    April 2018 Podcasts

    Jones Day Talks Health Care & Life Sciences: False Claims and Private Equity, and Rideshare Apps Race into Patient Transportation

    February 2018 Commentaries

    DOJ Pursues PE Firm Based on Portfolio Company's Alleged Payment of Kickbacks

    May 2017 Commentaries

    SEC's Unwavering Focus on Disclosure of Valuation Methods and Calculation of IRRs by Fund Sponsors

    January 2017 Commentaries

    U.S. Regulatory Action Items for Investment Advisers (2017)

    Speaking Engagements

    • June 7, 2012
      Jones Day Chicago 2012 MCLE University
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.